Bildkälla: Stockfoto

Moberg Pharma: Outcome of Rights issue – oversubscribed - Redeye

Redeye briefly comments on the news about the outcome of the rights issue. The subscription rate was 130%; thus, the rights issue was fully subscribed, and no issue guarantors were used. Moberg Pharma will receive SEK 100m before transaction costs.

Redeye briefly comments on the news about the outcome of the rights issue. The subscription rate was 130%; thus, the rights issue was fully subscribed, and no issue guarantors were used. Moberg Pharma will receive SEK 100m before transaction costs.
Börsvärldens nyhetsbrev
ANNONSER